Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prednisone Plus Levothyroxine Versus Only Levothyroxine to Treat RPL and RIF Women With Thyroisd Autoimmunity Positive to Embryotoxicity Test.

NCT06641440 is registered in ClinicalTrials.gov with Centre for Endocrinology and Reproductive Medicine, Italy as lead sponsor.

NCT NCT06641440
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06641440 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prednisone Plus Levothyroxine Versus Only Levothyroxine to Treat RPL and RIF Women With Thyroisd Autoimmunity Positive to Embryotoxicity Test.
Lead sponsor
Centre for Endocrinology and Reproductive Medicine, Italy
Phase
Phase 4
Overall status
Completed
Start date
January 1, 2018
Completion date
October 10, 2024
Enrollment
42 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

recurrent implantation failure, recurrent pregnancy loss, not pregnant